Akttyva Therapeutics, Inc.

CIK: 1910093DEIncorporated: 2020-10-22

Current Offering

$25,000
Target Amount
$1,000,000
Maximum Amount
2022-07-31
Deadline

Security Details

Type: SAFE Note
Price per share: $1.00
Shares offered: 25,000+

Offering Costs

Cash commission: 6%
6.0% of the Offering amount upon the successful completion. Intermediary may also be entitled to reimbursement for fee advances or out-of-pocket costs for third-party expenses it pays or incurs on behalf of the Issuer in connection with the Offering.
Equity compensation: 2%
1.5% of securities sold from a successful Offering.

Financial Reports

Offering via Fundify Portal

Offering History

As of 2022-03-01
Raising $25,000 -$1,000,000 via 25,000+ shares of sAFE Note at $1.00 per share
Deadline: 2022-07-31
Filing date2022-03-01
Current employees4
Act received most recent fiscal year$0.00
Act received prior fiscal year$0.00
Cash equi most recent fiscal year$420,402
Cash equi prior fiscal year$4,423
Cost goods sold most recent fiscal year$0.00
Cost goods sold prior fiscal year$0.00
Long term debt most recent fiscal year$200,000
Long term debt prior fiscal year$0.00
Net income most recent fiscal year-$37,738.00
Net income prior fiscal year-$4,409.00
Revenue most recent fiscal year$0.00
Revenue prior fiscal year$0.00
Short term debt most recent fiscal year$234,122
Short term debt prior fiscal year$555.00
Tax paid most recent fiscal year$1,148
Tax paid prior fiscal year$0.00
Total asset most recent fiscal year$420,402
Total asset prior fiscal year$4,423

Company Information

Corporation
DE
2020-10-22

Latest Metrics

Employees4
Total Assets$420,402
Cash on Hand$420,402
Revenues$0.00
Net Income-$37,738.00

Crowdfunding Portals

This company is raising funds through this portal